InMed Pharmaceuticals Inc... (INM)
NASDAQ: INM
· Real-Time Price · USD
2.32
-0.02 (-0.85%)
At close: Aug 15, 2025, 3:59 PM
2.32
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT
InMed Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | 6.87M | 6.66M | 6.71M | 6.21M | 7.52M | 7.33M | 6.31M | 5.53M | 3.13M | 2.12M | 1.83M | 1.39M | 724.67K | 337.86K | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 4.65M | 4.3M | 4.58M | 4.72M | 4.59M | 4.53M | 3.77M | 3.69M | 3.05M | 2.07M | 1.81M | 696.01K | 354.75K | 195.68K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 2.22M | 2.36M | 2.13M | 1.49M | 2.93M | 2.8M | 2.55M | 1.84M | 85.04K | 52.41K | 18.35K | 691.45K | 369.93K | 142.18K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -11.31M | -10.74M | -9.83M | -7.44M | -5.38M | -5.85M | -6.59M | -11.36M | -14.6M | -16.12M | -18.61M | -17.51M | -17.67M | -17.19M | -14.16M | -12.06M | -9.86M | -8.12M | -8.16M |
Interest Income | 286.73K | 427.95K | 605.08K | 711.83K | 766.9K | 812.39K | 746.94K | 662.21K | 508.8K | 337.17K | 215.07K | 122.09K | 84.67K | 50.75K | 21.15K | 18.98K | 21.85K | 43.41K | 80.02K |
Pretax Income | -11.64M | -10.96M | -9.21M | -10.37M | -8.18M | -8.54M | -9.4M | -10.77M | -20.46M | -22.1M | -24.74M | -23.7M | -17.6M | -17.15M | -14.56M | -12.39M | -10.31M | -8.44M | -8.07M |
Net Income | -11.65M | -10.97M | -9.22M | -10.38M | -8.18M | -8.55M | -9.41M | -10.79M | -20.47M | -22.11M | -24.75M | -23.7M | -17.6M | -17.15M | -14.56M | -12.39M | -10.31M | -8.44M | -8.07M |
Selling & General & Admin | 7.72M | 7.69M | 7.26M | 7.09M | 7.3M | 7.34M | 7.5M | 7.89M | 8.26M | 8.74M | 9.12M | 8.72M | 8.4M | 7.69M | 6.57M | 5.46M | 4.29M | 3.51M | 3.16M |
Research & Development | 5.52M | 5.11M | 4.4M | 5.1M | 4.28M | 4.57M | 4.91M | 5.05M | 6.15M | 7.16M | 9.25M | 9.25M | 9.44M | 9.47M | 7.44M | 6.46M | 5.41M | 4.46M | 4.87M |
Other Expenses | 299.97K | 299.8K | 296.5K | -3.26M | -3.95M | -6.86M | -9.87M | -11.09M | -14.33M | -15.85M | -18.34M | -13.61M | -9.72M | -5.33M | 153.04K | 144.87K | 157.4K | 150.07K | 131.29K |
Operating Expenses | 13.53M | 13.1M | 11.95M | 8.93M | 7.63M | 5.06M | 2.55M | 1.84M | 85.04K | 52.41K | 18.35K | 4.36M | 8.12M | 11.83M | 14.16M | 12.06M | 9.86M | 8.12M | 8.16M |
Interest Expense | 505.56K | 505.56K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 460.12K | 460.12K | 460.12K | 460.12K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 18.18M | 17.4M | 16.53M | 13.66M | 12.22M | 9.58M | 6.31M | 5.53M | 3.13M | 2.12M | 1.83M | 5.05M | 8.48M | 12.03M | 14.16M | 12.06M | 9.86M | 8.12M | 8.16M |
Income Tax Expense | 9.71K | 9.71K | 9.71K | 9.71K | 2.38K | 4.41K | 8.44K | 17.76K | 15.38K | 13.35K | 9.32K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.1M | 706.55K | 620.13K | 891.9K | 961.3K | 778K | 332.82K | 323.08K | 332.82K | 230.05K | 86.46K | 64.39K | 56.61K | 55.39K | 48.16K | 32.18K | 30.2K | 24.37K | 20.88K |
Shares Outstanding (Diluted) | 1.1M | 706.55K | 620.13K | 891.9K | 961.3K | 797.35K | 332.82K | 332.82K | 332.82K | 230.05K | 86.56K | 64.41K | 56.61K | 55.39K | 48.19K | 32.18K | 30.2K | 24.37K | 20.88K |
EPS (Basic) | -85.07 | -68.07 | -34.17 | -17.47 | -16.6 | -22.3 | -32.2 | -77.8 | -233.8 | -302.5 | -387.9 | -410 | -378.2 | -430.5 | -449.9 | -473.8 | -453.4 | -460.7 | -498.5 |
EPS (Diluted) | -85.07 | -68.07 | -34.17 | -17.47 | -16.7 | -22.4 | -32.3 | -78 | -233.9 | -302.6 | -388 | -410.1 | -378.3 | -430.6 | -450 | -473.8 | -453.4 | -460.7 | -498.5 |
EBITDA | -10.57M | -9.87M | -8.61M | -9.78M | -7.73M | -8.3M | -9.34M | -10.56M | -20.01M | -21.54M | -24.04M | -23.07M | -17.13M | -16.72M | -13.7M | -11.64M | -9.28M | -7.45M | -7.63M |
EBIT | -11.35M | -10.66M | -9.43M | -10.6M | -8.54M | -9.1M | -10.15M | -11.36M | -20.81M | -22.33M | -24.82M | -23.72M | -17.61M | -17.09M | -14M | -11.9M | -9.55M | -7.67M | -7.76M |
Depreciation & Amortization | 774.61K | 794.55K | 811.2K | 816.72K | 809.03K | 806.3K | 802.01K | 803.32K | 801.67K | 791.5K | 784.64K | 650.04K | 487.11K | 364.61K | 298.45K | 257.46K | 269.99K | 228.04K | 131.29K |